Patient-reported outcomes with the β3-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder

  1. Khullar, V.
  2. Amarenco, G.
  3. Angulo, J.C.
  4. Blauwet, M.B.
  5. Nazir, J.
  6. Odeyemi, I.A.
  7. Hakimi, Z.
Revue:
Neurourology and Urodynamics

ISSN: 1520-6777,  0733-2467

Année de publication: 2016

Volumen: 35

Número: 8

Pages: 987-994

Type: Article

DOI: 10.1002/NAU.22844 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus